Summary.-Ehrlich ascites tumours (EAT) were grown in mice by injecting 1 x 106 cells intraperitoneally. In mice which received one or more injections of 30 mg soybean trypsin inhibitor (TI) i.p. during tumour growth, the number of recoverable tumour cells was significantly reduced by up to 92%. Also, the mean size of these cells was significantly smaller.
Viability, assessed by trypan blue dye exclusion and rate of labelled chromium release, was the same in TI-treated and control cell populations. Thus TI was nontoxic to EAT cells and the reduced number of cells from treated tumours was not therefore due to cytotoxicity.
Scanning electron microscopy revealed that normal EAT cells did not adhere to internal host surfaces but that after TI treatment they adhered in lar e numbers to produce an appearance which resembled a confluent monolayer. This binding to host tissue accounted for the reduction in the number of cells recovered from TItreated animals. We propose that TI acts as a protease inhibitor to prevent intrinsic proteolytic enzyme activity at the tumour cell surface. This activity would normally destroy the binding sites required for adhesion to host tissue.
PLANT agglutinins such as concanavalin A (Con A) bind to carbohydrates at cell surfaces (Winzler, 1970) . Cells which have undergone malignant transformation are agglutinated by such treatment but most normal cells are not (Inbar and Sachs, 1969) . Treatment of such untransformed cells with proteolytic enzymes, however, renders them agglutinable (Inbar and Sachs, 1969; Nicolson, 1972) and Burger (1969) proposed that the changes in cell membrane architecture produced by proteases were the same as those resulting from malignant transformation. He subsequently correlated these surface changes with a loss of growth control in normal cells, by demonstrating a temporary loss of contact inhibition after trypsin treatment (Burger, 1970) . Burger and Noonan (1970) subsequently reported the restoration of contact inhibition to polyomatransformed 3T3 cells by coating them with a non-agglutinating Con A preparation obtained by trypsin digestion. On the basis of this evidence, we postulated that the abnormal growth characteristics of malignant cell populations in vivo may result from the same cell surface alterations which characterize transformed or protease treated cells in vitro, and which result in a loss of contact inhibition. We therefore attempted to establish some * Present address: Department of Cell Biology, University of Glasgow. degree of growth control in Ehrlich ascites tumours (EAT) by modifying the cell surface in the manner described by Burger and Noonan (1970) . Doses of 1 mg " monovalent " Con A (Burger and Noonan, 1970) (Burton, 1956) .
Non-tumour cell analysis. To investigate the normal cell population in the peritoneal cavity of non tumour-bearing mice, cells were removed in saline and counted using the Coulter counter settings described above.
Rates of DNA synthesis.-Three different types of experiment were undertaken to determine the rates of DNA synthesis in tumour cell populations using the rate of uptake of thymidine (methyl-H3) (1.5 mCi/ mouse; sp. act. 18-4 Ci/mmol) or thymidine-2-C14 (1-14-2-5 ,uCi/ml; sp. act. 53-59 mCi/ mmol) (Radiochemical Centre, Amersham, U.K.). For in vitro experiments cells were washed 3 times in ice cold phosphate buffered saline (Flow). Initially, rates of uptake in tumour cells treated with TI in vivo were compared with untreated control cells. In subsequent experiments untreated tumour cells were preincubated in TI (5 mg/ml) for 1 hour in vitro before incubation in labelled thymidine. In both types of experiment, cells were incubated with labelled thymidine for several hours and the specific activity of TCA precipitates was then determined using methods described by Whur and Weatherhead (1971) . In the third type of experiment a single tumour cell population was heavily labelled in vivo with twice daily injections of 250 ,uCi 3H labelled thymidine for a period of 3 days. This was followed by a cold thymidine chase, consisting of 1000 times the total amount of labelled thymidine administered, given as a single i.p. injection. After 24 hours the labelled cells were recovered, washed, and single doses of 1 x 106 cells were injected into 2 groups of mice. The next day one group received 30 mg of TI, the other saline only. The cells were recovered after 72 hours in vivo and the amount of thymidine label per cell was compared in the 2 groups, using the same methods as before.
Cell viability experiments.-Cell viability was assessed both by trypan blue dye exclusion and by monitoring labelled chromium release. In the case of trypan blue, a few drops of freshly harvested unwashed cells were mixed with a 0.10% solution of the dye.
Two hundred cells were then examined from each tumour, using a haemacytometer slide, and viability was expressed as the mean percentage of unstained cells. For chromium release experiments, washed cells were suspended at 1 x 106/ml in Eagle's minimal essential medium (Biocult, Paisley, U.K.) and incubated for 1 hour at 37TC in the presence of 4 ,ul/ml of 51Cr solution (aqueous sodium chromate, 6 ,ug Cr/ml, 1-03 mCi/ml, Radiochemical Centre, Amersham, U.K.). They were then washed in 4 changes of medium and incubated for a further 3 hours in fresh medium, after which time 51Cr release was measured by incorporating an aliquot of the cell-free medium into scintillation fluid. The cells were then killed by heating to 60TC for 20 min to determine total releasable radioactivity (Pickaver et al., 1972) . Scanning electron microscopy.-In order to observe the degree to which cells had adhered to intra-abdominal surfaces, a square of ventral abdominal wall was removed from tumour bearing mice, washed in cold phosphate buffered saline and fixed at 4°C in 2.5% glutaraldehyde. After immersion in several changes of buffered wash, samples were frozen in isopentane, cooled with liquid N2 and freeze dried at -20 to -40TC. After mounting on stubs, the samples were coated with gold palladium and examined in a Stereoscan microscope (Cambridge Instruments, Cambridge, U.K.). These observations were repeated on 5 separate occasions. by 92% (P< 0-001) when compared with the yield from control mice (Fig. 2) . Cells from treated mice were also significantly smaller (P <0-001).
Having established that TI caused a major reduction in the number and size of recoverable tumour cells after 8 days of tumour growth, we investigated its effect on cell populations after shorter periods of tumour growth. Even when mice were killed on Day 2, after only a single injection of TI (Fig. 3) , there was a significant reduction in the mean total number of recoverable cells (P <0-02) and in their size (P <0-01). A feature not previously observed was the presence of 2 separate peaks in the cell size distribution of the untreated control group (Fig. 3) (Fig. 4a) . Predictably, the effect of the TI was to reduce significantly both the mean total number (P <0 02) and size (P <0 02) of the recoverable cells. Aliquots of 1 x 106 cells of either population were then injected into 2 groups of fresh mice and the tumours were allowed to grow for 5 days without further treatment. On Day 5 the tumours from each group had become indistinguishable in respect of mean total number (P >0 9) and size (P >0 9) (Fig. 4b) , indicating that the recoverable cells from TI-treated and control animals formed a single homogeneous population.
In order to establish how long the double peak observed in untreated controls on Day 2 (Fig. 3) persisted, a further experiment was carried out in which animals were killed on Day 4. By this time, the size distribution of cells in control animals had reverted to the single 670 jUm3 peak observed at later times (Fig. 5 ). There were significant differences between the groups in respect of mean total number of recoverable cells (P <0 05) and their size (P <0-01).
Since it wAas a constant feature of these experiments that the mean size of cells recovered from TI-treated mice was significantly less than that from controls, this change in size was investigated by determining the mean DNA content per cell in these 2 groups on Day 4 (Table I) . Whilst the mean cell size of the TI-treated group was again lower than that of the control group (P <0 05), there was no significant difference in DNA content per cell between the groups (P >0 5).
Effect of TI on normal peritoneal cell population Six hours after i.p. injection of 30 mg of TI into non tumour-bearing mice, the size of the peritoneal cell population recovered in saline was not significantly different from that of control mice (P >0 5) (Table II) . 
Toxicity of TI to EAT cells
Since the smaller number of cells recovered from TI-treated tumours was not the result of a slower growth rate, we examined the possibility that it was due to cytotoxicity. As measured by trypan blue dye exclusion, there were no more dead cells present in the TI-treated populations than in the controls (Table  IV) . This observation assumes that dead (Fig. 1-5 ). Cell size distribution analysis indicated that this reduction was not attributable to tumour cells aggregating in vivo. Even in groups of mice killed on Day 2 after a single injection of TI (Fig. 3) there was a reduction of 7500 in the number of recoverable cells. This reduction was not attributable to a TIinduced initial lag phase in the growth rate, since the mean rate of cell division during the first 72 hours following transplantation was significantly greater in TI-treated than in control cell populations (Table III) .
There was also a significant difference in the mean size of control cells (700-800 1Im3) compared with TI-treated cells (400-600 pm3). After 2 days of tumour growth and a single injection of TI, the treated group showed a single peak at 270 jUm3, whereas the untreated control cells showed 2 peaks (Fig. 3) . By Day 4 the controls peaked only at 670 11m3 whereas the treated group persisted at 270 ,um3 (Fig. 5 ) and this subsequently remained unchanged. When such cells were injected in equal amounts into fresh mice they produced recoverable cell populations which were identical both in respect of total number and mean size, irrespective of whether they originated from TI-treated or control mice (Fig.  4a,b) . Thus the 2 populations are composed of similar cells, the difference in size being attributable to the action of TI. This difference in size is not, however, clearly correlated with a change in DNA content (Table I) . It cannot therefore be attributable to the change in size which is seen in EAT and other tumour cells as a consequence of the reduced ploidy resulting from the increased growth rate which follows tumour transplantation (Basleer and Desaive, 1971; Dombernowsky, Bichel and Hartmann, 1973 removed from the medium or from the cell surface during the washing and dilution procedures associated with this series of experiments. We therefore modified the design, using hitherto untreated tumour cells which were preincubated in vitro with TI before comparing the rate of thymidine incorporation with that of untreated control cells. Again, however, no significant differences were observed. In order to reflect more accurately the conditions in vivo, we used a population of cells whose DNA had been prelabelled with 3H-thymidine, to observe the decline in the level of labelling per cell when grown in TI-treated or control mice. Cells recovered from TI-treated mice contained a significantly lower level of label and were therefore undergoing mitosis at more frequent intervals (Table III) . Since analysis of tumour cell kinetics in control mice suggested that growth is almost exponential for the first 10 days after the injection of 1 x 106 tumour cells, the figures in Table III Toxicity of TI The fact that the viability of TItreated cells, as judged by the exclusion of trypan blue dye, was the same as that of controls (Table IV) does not entirely exclude the possibility that TI was toxic to the cells, unless we assume that dead cells persist for a sufficient period to represent a statistically detectable propor-tion of the total population. This problem was eliminated by the observation that cells preincubated in 51Cr released label at the same rate when incubated in vitro, whether or not TI was added to the incubation medium (Table V) . On the basis of these observations, it is apparent that TI does not kill or lyse cells at the concentrations used and the reduction in the number of cells recovered from TI-treated mice cannot be attributed to such an effect.
Adhesion of tumour cells to host tissues
Our line of EAT cells does not normally adhere to the internal abdominal surfaces of the host in which it is grown (Fig. 6) . Consequently, the mean number of cells recoverable from untreated mice accurately reflects the actual tumour size. When such tumours were treated with TI the number of cells subsequently recovered was markedly reduced when compared with controls. This was due to large numbers of cells adhering to the host's tissues as a result of TI treatment (Fig. 7) and not to any cytotoxic effect or alteration in growth rate. Direct evidence that the adhering cells are indeed tumour cells is being prepared at the moment, but present evidence indicates that they are not inflammatory cells. Cells from TI-treated and control animals formed a single homogeneous population (Fig. 4a,b) , which would not be the case if a substantial number of cells from the TI-treated mice were peritoneal macrophages. Furthermore, the normal peritoneal cell population of non tumour-bearing mice was unaltered 6 hours after TI injection (Table II) (Nicolson, 1972) . Consequently, if TI forms bridges between tumour cells and host cells it is also necessary to postulate that the host cell binding sites are exposed in the " reorientated" manner under normal conditions. For these reasons it appears extremely unlikely that TI mediates the adhesion of tumour and host cells by such a mechanism.
A more likely possibility is that TI alters the surface of either the host or the tumour cell in such a way as to complete a system of binding sites directly linking the two cell types. This linkage would have a degree of specificity to account for the failure of tumour cells to bind to each other. The presence of TI may allow the build up of specific binding sites on the tumour cell surface, by inhibiting an intrinsic protease of tumour origin which otherwise destroys the sites. This hypothesis is supported by the demonstration that the agglutination of EAT cells by Con A is greatly enhanced by preincubation with TI, (Payne, Whur and Robson, 1973) . Presumably Con A agglutination sites are increased in the presence of this protease inhibitor, in line with the finding that the agglutination of transformed cells by Con A is reduced after trypsin treatment (Inbar and Sachs, 1969) . We postulate, therefore, that EAT cells bind to host tissue as a result of the inhibition by TI of intrinsic proteolytic activity. This hypothesis receives support from observations which indicate that treatment of malignant cells with protease inhibitors in vitro results in an alteration of growth characteristics, which may result from modification of the cell surface (Goetz, Weinstein and Roberts, 1972; Schnebli and Burger, 1972) . Our findings support the view that the abnormal growth rates and adhesive properties of tumour cells are related to modification of cell surface binding sites by the activity of intrinsic proteases.
